This Government Contract opportunity was posted on August 20, 2012. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Evaluation of Risk of Narcolepsy/Pandemrix
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Centers for Disease Control and Prevention intends to contract with the Brighton Collaboration in Switzerland to extend a scientific study evaluating the risk of narcolepsy associated with Pandemrix and Arepanrix vaccines. This project aims to build upon a multi-country European study to further assess the association between these specific adjuvanted and non-adjuvanted H1N1 vaccines and the development of narcolepsy across European and non-European countries, including Canada. Due to their role as the primary contractor for the initial study and their unique technical and administrative expertise in vaccine safety research, the Brighton Collaboration is identified as the sole source capable of satisfying the requirements. The anticipated period of performance for this effort is two years from the date of award.
General Info
Agency
Contract Value
$1,236,336Place of Performance
Europe, CHESet-Aside
Award Issued Date
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
